E. Tryggestad
Johns Hopkins Medicine, Johns Hopkins University, Mayo Clinic
Papers
5
Total Citations
485
H-Index
5
About
Erik Tryggestad is a leading figure in radiation oncology physics, whose work bridges cutting-edge technology and clinical precision. His primary research areas include small animal irradiation, image-guided therapy, and advanced treatment planning for both photon and proton therapies. Tryggestad’s most impactful contribution is the development and validation of the Small Animal Radiation Research Platform (SARRP), a high-resolution system that delivers focal kilovoltage radiation under cone-beam CT guidance. This work, published in 2008, has garnered over 360 citations and revolutionized preclinical radiotherapy by enabling precise, image-guided targeting in small animal models. He further strengthened this foundation with a comprehensive dosimetric commissioning and Monte Carlo validation study, cited 81 times. Beyond small animal work, Tryggestad has advanced clinical applications, including deformable image registration for transoral robotic surgery and a novel 3D patient-specific collision avoidance framework for half-gantry proton therapy. His forward-looking perspective is evident in his 2023 commentary arguing that 4DCT technology is “long overdue for improvement,” reflecting his ongoing commitment to innovation. With a career defined by translational impact—from bench to bedside—Tryggestad continues to shape the future of precision radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 44DCT is long overdue for improvement12 citations · 2023
- 5